Boutique Biotech

Home
Archive
About
Milestone Pharmaceuticals in the spotlight (part III)
Selling MIST position to lock in 30% gains
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
New
Top
Community
Obesity in the spotlight
Assessing big Pharma vs. small-to-mid-cap bios
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
ASCO 2023 Highlights
ADCs, NK Cell Engagers, TIGIT, and more updates...
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
Pfizer in the spotlight
Oral obesity treatments & competitive landscape assessment in GLP-1 market
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
Amgen & Horizon Therapeutics in the spotlight
FTC Pauses Biotech Rally, But Show Must Go On...
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
Biotech Basics: Interpreting Data Readouts
Educational content for biotech investing
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
Eli Lilly in the spotlight
Assessing latest data in Alzheimer's disease
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
$VKTX, $GPCR, $RYTM, $ACIU, $VYGR, $KRTX, $ITCI, $PRQR, $ARWR, $ALNY, and more...
Bullish trends & names to watch for in the biotech market
 • 
Bohdan (Bo) Khomtchouk, Ph.D.
Boutique Biotech
Boutique Biotech
Boutique insights into the biotech stock market. Not investment advice.

Boutique Biotech

AboutArchiveSitemap
© 2023 Bohdan (Bo) Khomtchouk, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing